What Does The C-Suite Debate The Most? New Survey Reveals The Answer
Which hot-button issues are sparking debate among enterprise leaders? The Forbes Research 2025 CxO Growth Survey, which polled more than 1,000 global C-suite executives between November and December 2024, finds that the most divisive topic is technology investment, cited by 40% of respondents.
Source: 2025 Forbes CxO Growth Survey
But when you drill down by role, each executive group lights up a different area of contention. Below, explore what each CxO perceives as the most polarizing items on the executive agenda.CEOs Point To Strategic Direction Over Tech
Chief executive officers are most likely to say that C-suite debate focuses on strategic direction, such as where to steer transformation and whether to increase their enterprise's footprint. They're also particularly sensitive to contention around how best to collaborate, cited by 33% of CEOs compared to 24% of CxOs overall.
Only 29% of CEOs — the least of any C-suite role — identify tech investment as a leading debate topic, compared to 40% of all respondents.CFOs Say Resource Allocation Dominates Discussions
Among all C-suite roles, chief financial officers are most acutely sensitive to disagreements around technology investment.CIOs See Tech Infrastructure As The C-Suite Focal Point
As chief investment officers see it, executives are most divided on cloud strategy.
CIOs are less sensitive to debates around where to grow the organization (13%), how to best collaborate (14%) and management philosophy or decision-making procedures (21%) — listing these topics less than any other CxO role.CHROs Perceive Hiring And Retention As Most Contentious
Nearly a third of chief human resources officers (32%) also cited managing a hybrid workforce as a key topic of debate.CMOs Are Tuned Into Tech Debates
AI and technology investments are the leading C-suite disagreements according to chief marketing officers — a majority of whom plan to increase marketing spends on digital transformation initiatives, data analytics tools, acquiring AI-driven insights and AI agents over the next 12 months.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Asian Growth Companies With Insider Ownership Ranging From 16% To 36%
As global markets respond to favorable trade developments, with indices like the S&P 500 and Nasdaq Composite reaching record highs, attention turns to Asia where growth companies are capturing interest amidst a backdrop of trade negotiations and economic adjustments. In this environment, stocks with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the company's operations and strategy. Top 10 Growth Companies With High Insider Ownership In Asia Name Insider Ownership Earnings Growth Zhejiang Leapmotor Technology (SEHK:9863) 15.6% 60.9% Vuno (KOSDAQ:A338220) 15.6% 109.8% Techwing (KOSDAQ:A089030) 18.8% 68% Suzhou Sunmun Technology (SZSE:300522) 35.4% 77.7% Samyang Foods (KOSE:A003230) 11.7% 27.2% Oscotec (KOSDAQ:A039200) 12.7% 98.7% Novoray (SHSE:688300) 23.6% 28.2% Laopu Gold (SEHK:6181) 35.5% 42.8% Gold Circuit Electronics (TWSE:2368) 31.4% 26.5% Fulin Precision (SZSE:300432) 13.6% 43.7% Click here to see the full list of 584 stocks from our Fast Growing Asian Companies With High Insider Ownership screener. Let's explore several standout options from the results in the screener. Ocumension Therapeutics Simply Wall St Growth Rating: ★★★★★☆ Overview: Ocumension Therapeutics is an ophthalmic pharmaceutical platform company operating in the People's Republic of China with a market cap of HK$8.64 billion. Operations: The company generates revenue of CN¥417.31 million from its activities focused on discovering, developing, and commercializing ophthalmic therapies in China. Insider Ownership: 16.1% Ocumension Therapeutics is poised for significant growth, with forecasted revenue and earnings set to rise substantially. Despite recent shareholder dilution, insider ownership remains robust, with more shares bought than sold in the past three months. The company is advancing its innovative pipeline, notably OT-802 for presbyopia and OT-703 for diabetic macular edema. Recent board changes reflect a commitment to strong governance as they navigate the high-growth potential of underserved markets in Asia. Dive into the specifics of Ocumension Therapeutics here with our thorough growth forecast report. Upon reviewing our latest valuation report, Ocumension Therapeutics' share price might be too optimistic. SG Micro Simply Wall St Growth Rating: ★★★★★☆ Overview: SG Micro Corp designs, markets, and sells analog integrated circuits across Mainland China, Hong Kong, Taiwan, and internationally with a market cap of CN¥44.84 billion. Operations: The company's revenue is derived entirely from the Integrated Circuit Industry, totaling CN¥3.41 billion. Insider Ownership: 32.7% SG Micro is experiencing strong growth, with earnings projected to increase significantly, outpacing the market. Revenue growth is also expected to exceed the market average. Despite no recent substantial insider trading, insider ownership remains significant. The company recently approved a stock option incentive plan and made amendments to its articles of association, indicating strategic alignment for future expansion. A cash dividend was declared at their AGM, reflecting financial stability amidst rapid growth projections. Click here and access our complete growth analysis report to understand the dynamics of SG Micro. According our valuation report, there's an indication that SG Micro's share price might be on the expensive side. Visional Simply Wall St Growth Rating: ★★★★☆☆ Overview: Visional, Inc., along with its subsidiaries, offers human resources platform solutions in Japan and has a market cap of approximately ¥456.55 billion. Operations: The company's revenue is primarily derived from its HR Tech segment, which generated ¥73.55 billion, and its Incubation segment, contributing ¥2.52 billion. Insider Ownership: 36.8% Visional shows promising growth prospects with earnings and revenue expected to grow faster than the Japanese market. Recent board meetings highlighted strategic acquisitions, including BizReach's plan to acquire Thinkings, Inc., supporting sustained expansion. The company raised its earnings forecast due to robust BizReach performance, projecting net sales of ¥79.5 billion and profit attributable to owners of parent at ¥14.39 billion for FY2025. Despite high share price volatility, Visional trades below estimated fair value with strong insider ownership stability. Click here to discover the nuances of Visional with our detailed analytical future growth report. In light of our recent valuation report, it seems possible that Visional is trading beyond its estimated value. Where To Now? Access the full spectrum of 584 Fast Growing Asian Companies With High Insider Ownership by clicking on this link. Curious About Other Options? Uncover 13 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include SEHK:1477 SZSE:300661 and TSE:4194. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
Microsoft's Xbox Shoots to PlayStation Top?10
Microsoft (NASDAQ:MSFT) saw shares tick up after six of the ten best?selling games on Sony's PlayStation turned out to be Xbox titles. You read that right; Forza Horizon 5, The Elder Scrolls IV: Oblivion Remastered, Call of Duty: Black Ops 6, Doom: The Dark Ages, Indiana Jones and the Great Circle, plus Minecraft all cracked PlayStation's top ten. Only MLB: The Show 25 and Death Stranding 2: On the Beach were Sony exclusives. Warning! GuruFocus has detected 7 Warning Sign with MSFT. This crossover success highlights how Microsoft's multi?console strategy and Game Pass ecosystem are reshaping gaming habits. With Game Pass topping 37 million subscribers, Microsoft bundles day?one Xbox releases into a $16 monthly subscription, while Sony's $10 PlayStation Plus still lacks first?party day?one titles. On top of that, Xbox Cloud Gaming is live in over 25 markets, letting you stream blockbuster games on phone or tablet without a console. This article first appeared on GuruFocus.
Yahoo
18 minutes ago
- Yahoo
Altria (MO) Extends $3B Credit Line Amid Strong Dividend History
Altria Group, Inc. (NYSE:MO) is one of the defensive stocks that billionaires are buying amid US trade tariff uncertainty. On July 23, Altria Group announced an extension of its $3.0 billion five-year revolving credit agreement, shifting the expiration date from October 2028 to October 2029. The deal, originally signed in October 2023, involves JPMorgan Chase and Citibank as administrative agents. All other terms remain unchanged. Altria continues to maintain a strong financial position, offering a robust 6.83% dividend yield and making payouts for 55 consecutive years. The involved lenders already provide Altria with financial services, including investment banking, trust operations, and cash management. Altria Group, Inc. (NYSE:MO) is a leading American tobacco company known for producing and marketing cigarettes and related products worldwide, while also expanding into innovative nicotine alternatives like electronic vaping devices and oral nicotine pouches as part of its strategy to diversify its portfolio and adapt to shifting consumer preferences. While we acknowledge the potential of MO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best 52-Week High Stocks to Buy Now and 10 Best Biotech Stocks to Buy According to Billionaire Steve Cohen. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
